• No results found

[PDF] Top 20 Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study

Has 10000 "Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study" found on our website. Below are the top 20 most common "Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study".

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study

... for treatment and the baseline measurement value as a ...primary analysis of change from baseline to endpoint in MADRS total ...primary analysis were performed using observed case and a mixed-effects ... See full document

11

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double blind, placebo controlled study

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double blind, placebo controlled study

... anese patients. All tests of treatment effect were conducted at a 2-sided significance level of ...using analysis of covariance models with type III sums of squares with a term for treatment ... See full document

10

Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trial

Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trial

... multicenter, randomized, double-blind, placebo-controlled clinical trial will include 80 patients undergoing ...The patients will be randomized in a 1:1 ratio to a ... See full document

7

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy

... clinical study performed in pediatric patients highly refractory to treatment distributed into three age groups: 2–6 years (group 1, eleven patients), 7–11 years (group 2, eight ... See full document

10

New developments in the management of partial-onset epilepsy: role of brivaracetam

New developments in the management of partial-onset epilepsy: role of brivaracetam

... the treatment of POS in patients older than 16 years of ...clinical efficacy as adjunctive antiepileptic treatment in adults with refractory POS at doses between 50 and 200 mg daily has been ... See full document

15

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments

... current treatment strategies for the management of sepsis-induced ...the treatment of sepsis-induced DIC ...the treatment is provided to those with sepsis-induced DIC rather than all patients ... See full document

5

Mirogabalin and emerging therapies for diabetic neuropathy

Mirogabalin and emerging therapies for diabetic neuropathy

... In addition to efficacy, this Phase II trial assessed the safety of mirogabalin using adverse event (AE) data, clinical laboratory tests, and electrocardiograms. Most frequent AEs (n = 277) were mild to ... See full document

8

Novel design for a phase IIa placebo controlled, double blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia

Novel design for a phase IIa placebo controlled, double blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia

... In patients with the classical type, the attacks come on suddenly, last up to 2 min and disappear ...attacks, patients are usually asymptomatic, although there may be a slight after pain ...TN ... See full document

11

A randomized, double blind, placebo controlled trial to assess the efficacy of topiramate in the treatment of post traumatic stress disorder

A randomized, double blind, placebo controlled trial to assess the efficacy of topiramate in the treatment of post traumatic stress disorder

... term randomized controlled medication trials for PTSD (4597 ...of patients (644 participants), while response to placebo was seen in ...of patients (628 ...for patients who ... See full document

7

Recent advances in the treatment of multiple sclerosis

Recent advances in the treatment of multiple sclerosis

... in patients with MS, and most adverse events were rated as ...the patients showed a reduction in myelin basic protein (MBP) proliferation within 2 months of infusion and decreased IFN- γ production by ... See full document

7

Clinical utility and patient adherence with ebastine for allergic rhinitis

Clinical utility and patient adherence with ebastine for allergic rhinitis

... by patients to justify their failed adherence is ...and safety. On the other hand, it has been reported that patients are well motivated to adhere to a treatment when they understand and ... See full document

7

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder

... the efficacy data and other relevant details of these 12 ...involve patients who presented an episode of major depression (Diag­ nostic and Statistical Manual of Mental Disorders [DSM-IV] criteria) ... See full document

11

Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment

Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment

... included patients on psychotropic agents (eg, antipsychotics, antidepressants, anticonvulsants), suggesting the presence of a comorbid psychiatric illness and dual diagnosis of AUD with a mood or thought ...in ... See full document

12

Efficacy and safety of <em>Ginkgo biloba</em> standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial

Efficacy and safety of <em>Ginkgo biloba</em> standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial

... each study visit, visits 2–7. Adverse reac- tions were reported to the study clinical monitor and study steering ...committee. Treatment adherence was checked for all subjects by inquiry and ... See full document

8

Treatment of neurolept-induced tardive dyskinesia

Treatment of neurolept-induced tardive dyskinesia

... of TDK of 26%, 52%, and 60% at 1, 2, and 3 years, respectively. The movements observed need to be distinguished from schizophrenia stereotypies and mannerisms, as well as other causes of orolingual movements, such as ... See full document

10

Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature

Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature

... existing within and between studies. Additional limitations of this review reflect the limitations of the existing literature on vortioxetine effectiveness for treating MDD in adults. A large number of the reviewed ... See full document

20

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection

... of bipolar patients with a low level of treatment ...including patients with a history of poor adherence to treatment have found that RLAI improved therapeutic efficacy in the ... See full document

10

Treatment of Multiple Sclerosis

Treatment of Multiple Sclerosis

... [28] Sanofi-Aventis 2016 An International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Year Treatment with[r] ... See full document

9

Linagliptin: from bench to bedside

Linagliptin: from bench to bedside

... were randomized to receive open-label vildagliptin (n = 53) or treatment with non-DPP-4 antidiabetic therapies (n = 53) for 3 ...the study, more patients receiving vildagliptin (16/53) ... See full document

16

Evidence-based guideline: Treatment of tardive syndromesReport of the Guideline Development Subcommittee of the American Academy of Neurology

Evidence-based guideline: Treatment of tardive syndromesReport of the Guideline Development Subcommittee of the American Academy of Neurology

... as treatment because neuroleptics may cause TDS despite masking ...TDS treatment (Level C). Diltiazem should not be considered as TDD treatment (Level B); galantamine and eicosapen- taenoic acid may ... See full document

9

Show all 10000 documents...